Brief: Nicox’S U.S. Licensee Eyevance Expands U.S. Promotion Of ZERVIATE In Agreement With Hikma

Nicox SA

15/02/2021 06:40

Feb 15 (Reuters) - NICOX SA  NCOX.PA :
    * NICOX’S U.S. LICENSEE EYEVANCE EXPANDS U.S. PROMOTION OF
ZERVIATE IN AGREEMENT WITH HIKMA
    * HAS ENTERED INTO A PARTNERSHIP WITH HIKMA PHARMACEUTICALS
FOR
CO-PROMOTION OF ZERVIATE®, INDICATED FOR TREATMENT OF OCULAR
ITCHING ASSOCIATED WITH ALLERGIC CONJUNCTIVITIS
    * HIKMA WILL BE RESPONSIBLE FOR PROMOTING ZERVIATE TO U.S.
HEALTHCARE PROFESSIONALS WORKING OUTSIDE EYECARE SPECIALTY, WITH
ALL SALES CONTINUING TO BE BOOKED BY EYEVANCE, ON WHICH NICOX
WILL RECEIVE ROYALTIES

Source text for Eikon:  ID:nGNE6vSmWp 
Further company coverage:  NCOX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))